Work

Improved Diagnosis and Therapy of Hymenoptera Venom Allergy by Component-Resolved Approaches

Year: 2018
Type: dissertation
Abstract: Patients suffering from allergies due to stings of Hymenoptera like Apis mellifera, Vespula vulgaris and Polistes dominula can experience severe to fatal anaphylactic reactions.Besides emergency treatment, venom immunotherapy (VIT) is the only curative treatment.VIT products are available from different manufactures and treatment efficacy is very high compared to other forms of allergen-specific immunotherapy.Nevertheless, therapeutic failures can be observed and possibly originate from different venom extraction or work-up techniques.To reduce the cost resulting from unnecessary treatment with more than one venom and to avoid the chance of de novo sensitization, the identification of the insect causing the systemic reaction has to be unambiguous.Not all patients can correctly identify the causative insect and, moreover, diagnosis by skin testing is not always straightforward.Therefore, serum specific immunoglobulin E (sIgE) levels to crude insect venom can be determined in routine diagnosis.In the past, this was shown to have several disadvantages, as single allergens can be underrepresented in venom extracts due to low biologic availability or stability, thus patients sensitized to those allergens might be missed.Furthermore, patients with clinically irrelevant sIgE reactivity to cross-reactive carbohydrate determinants (CCDs), might be tested (false) positive to the venoms of Apis mellifera and Vespula vulgaris.However, double-positive sIgE diagnostic test results can also originate from homologous proteins in the venoms of Apis mellifera, Vespula vulgaris and Polistes dominula.The introduction of single venom allergens for routine diagnosis by recombinant techniques advanced molecular and component-resolved diagnosis of insect venom allergy.Since the beginning of the new millennium, many Apis mellifera and Vespula vulgaris venom allergens have been identified.Additionally, marker allergens were identified and produced without CCD-reactivity, thus patients showing double-positive diagnostic test results to Apis mellifera and Vespula vulgaris venom extracts can be diagnosed with high sensitivity and specificity.Discriminating marker allergens are missing for the diagnosis of patients with suspected Vespula vulgaris and Polistes dominula venom allergy.As both species coexist in the Mediterranean regions of Europe, double-positive tested patients or patients sensitized to both species are frequently observed.As Polistes dominula is invading northern regions due to climate changes, venom allergy to stings of this species is most likely to spread in the same manner.In the first part of this thesis, the available and already identified Vespula vulgaris and Polistes dominula major venom allergen, antigen 5, was used together with the homologues from other related allergy-relevant Hymenoptera species to demonstrate the present diagnostic challenges.In the next part, the state-of-the-art diagnostic and therapeutic options for Hymenoptera venom allergy were reviewed.Additionally, a previously unknown Polistes dominula venom allergen, the dipeptityl peptidase IV, was identified and demonstrated to be a major allergen.Furthermore, the generation of recombinant venom allergens was employed to generate tools to study the composition of available therapeutic venom extracts used for the treatment of Apis mellifera venom allergy.Thereby, a possible reason for treatment failures of Apis mellifera venom allergic patients was demonstrated by the lack and instability of allergens in some therapeutic venom preparations.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W2945194134
Cites: 340
Cited by:
Related to: 10